Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have achieved breakthroughs in mimicking human biology and won its top scientists the Nobel Prize in Chemistry. Now Isomorphic Labs, the division within the software giant meant to develop and commercialize the technology, is taking another big step: raising money…

Read More

5 U.S. Voters Weigh In on the Signal Leak

The White House has spent the week trying to downplay the revelation that top national security officials discussed plans for U.S. strikes in Yemen on Houthi militants over Signal, a commercial messaging app. In a stunning breach of national security, the Defense Secretary, Pete Hegseth, disclosed specific operational details before the attacks in the group…

Read More

CoreWeave Disappoints on Opening of Trading

Shares of CoreWeave, the first artificial intelligence start-up to go public, finished its first day of trading at $40.01 a share, one penny above the disappointing initial public offering price the company had set a day earlier. The company’s share price, trading under the ticker symbol CRWV, signaled concern among Wall Street investors about the…

Read More

The Tech Behind Signalgate + Dwarkesh Patel’s ‘Scaling Era’ + Is A.I. Making Our Listeners Dumb?

Listen to and follow ‘Hard Fork’Apple | Spotify | Amazon | YouTube | iHeartRadio This week, we dig into the group chat that’s rocking the Trump administration and talk about why turning to Signal to plan military operations probably isn’t a great idea. Then, we’re joined by the podcaster Dwarkesh Patel to discuss his new…

Read More